Clinical Trial Update: Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of Leuvectin followed by surgery in patients with Stage II or Stage III prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuvectin

Snippet

Sponsor: Vical | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED